[EN] DEUTERATED TETRAHYDRONAPHTHALENE DERIVATIVES<br/>[FR] DÉRIVÉS DE TÉTRAHYDRONAPHTALÈNE DEUTÉRÉS
申请人:CONCERT PHARMACEUTICALS INC
公开号:WO2011109464A1
公开(公告)日:2011-09-09
This invention relates to novel tetrahydronaphthalene derivatives, and pharmaceutically acceptable salts thereof according to the following formulae (B, A, 1), in one embodiment, as described herein. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a selective T-type calcium channel blocker.
established, asymmetric hydrogenation of challenging tetrasubstituted α,β‐unsaturatedcarboxylicacids is rarely reported. We demonstrate enantioselective hydrogenation of cyclic and acyclic tetrasubstituted α,β‐unsaturatedcarboxylicacids via cobalt(II) catalysis. This protocol showed broad substrate scope and gave chiral carboxylicacids in good yields with excellent enantiocontrol (up to 98 % yield and